Document is current

Evaluation of outcomes of 8-week therapy with ledipasvir/sofosbuvir or glecaprevir/pibrentasvir in veterans with hepatitis C infection

Crossref DOI link: https://doi.org/10.29328/journal.acgh.1001011

Published Online: 2019-11-13

Update policy: https://doi.org/10.29328/crossmark-policy